Genmab A/S (GMAB) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 19.14B |
| Enterprise Value | 22.86B |
| P/E Ratio | 44.33 |
| PEG Ratio | -0.53 |
| Price/Sales Ratio | 7.53 |
| Price/Book Ratio | 5.1 |
| Enterprise/Revenue | 8.3 |
| Enterprise/EBITDA | 25.84 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.17 |
| Operating Margin | 0.31 |
AD
Management Effectiveness
| Return On Assets | 0.06 |
| Return On Equity | 0.12 |
Income Statement
| Revenue | 3.72B |
| Revenue/Share | 7.02 |
| Gross Profit | 3.41B |
| EBITDA | 1.34B |
| Net Income | 963.76M |
| Diluted EPS | 1.54 |
Balance Sheet
| Total Cash | 1.86B |
| Total Cash/Share | 3.03 |
| Total Debt | 5.2B |
| Total Debt/Equity | 0.82 |
| Current Ratio | 2.45 |
| Book Value Per Share | 10.33 |
Price History
| 52-Week Change | 73.97 |
| 52-Week High | 59.97 |
| 52-Week Low | 23.62 |
| Moving Average 50 Days | 40.05 |
| Moving Average 200 Days | 31.26 |
Statistics
| Average Volume | 4.18M |
| Shares Outstanding | 614.95M |
| % Held by Institutions | 16.7 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 5:1 |
| Last Split Date | May 01, 2018 |
AD
